`
Monday, 26 June 2017

Biologics News

  • miRNA tools market clocked $110 mn in 2012: Frost

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013

    Singapore: Rapid growth in microRNA (miRNA) research over the past two years, which is fuelled by its diagnostic and therapeutic potential, has led to the the global miRNA tools and service...Read more

  • China to offer personalized chemotherapy

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2014

    Singapore: China-based Fosun diagnostics and Saladax Biomedical announced the launch of MyCare assay tests for chemotherapy in China. Saladax Biomedical in partnership with Fosun diagnostic...Read more

  • Green Cross to set up cell therapy plant in China

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2015

    Singapore: Green Cross, South Korean biopharmaceutical company, is expanding its manufacturing base by building a new cell therapy manufacturing facility in Guizhou province of China. The n...Read more

  • Takeda partners with Monash University

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2014

    Singapore: The Japanese pharma major Takeda, recently announced that the company has entered into a strategic partnership with Monash Institute of Pharmaceutical Sciences (MIPS) at Monash U...Read more

  • Taiwan researchers find link between obesity and arterial stiffness

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 29 Dec, 2014

    Singapore: According to a recent research at Taiwan based National Cheng Kung University (NCKU), obesity leads to a reduction in the protein lysyl oxidase (LOX) which accelerates aortic agi...Read more

  • DNA repair drug could treat leukaemia: Singapore

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 25 Aug, 2014

    Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designed for killing a limited type of cancer cells with DNA repair defects ...Read more

  • Singapore's AYOXXA closes $12.2 mn funding round

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2014

    Singapore: Singapore and Germany based biotech company, AYOXXA Biosystems, has completed $12.28 million (€9 million) Series B financing round. AYOXXA Biosystems has developed a propr...Read more

  • Biosimilars to take over biologic market by 2019'

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2014

    Singapore: The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected compound annual growth rate (CAG...Read more

  • Japanese nod for Janssen psoriatic arthritis drug

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2013

    Singapore: European Commission has approved Janssen-Cilag International's Stelara (ustekinumab), as a stand-alone drug or in combination with methotrexate, for the treatment of active psori...Read more

  • Chinese govt delay hinders GMP plant set up

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Jan, 2013

    Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced that the construction of a new production facility at its Guizhou ...Read more

  • German firm gets EU patent for dsRNA modification

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2013

    Singapore: German company, Riboxx Pharmaceuticals, received patent from European Patent Office (EPO) on a novel process for the manufacturing of double-stranded RNA (dsRNA) bearing chemical...Read more

  • 3SBio acquires patents for kidney failure drug

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2013

    Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acquired patents for DJ5, a novel non-TZD PPARgamma agonist with potentia...Read more

  • Asia leverages on the biologics opportunity

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of active pharmaceutical ingredients, but they still need to build their s...Read more

  • Now remote monitoring service via smartphone

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2014

    Singapore: AB SCIEX, life science analytical technologies provider, has launched StatusScope Remote Monitoring service, a configurable, real-time offering that supports most AB SCIEX mass s...Read more

  • Agilent launches biology solution for protein analysis

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014

    Singapore: Global supplier firm, Agilent Technologies, has launched QuikChange HT Protein Engineering System, a novel synthetic biology solutions for rational mutagenesis that creates libra...Read more

  • Belgian doctors develop new test tube baby system

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013

    Singapore: As a solution to the lack of affordable test tube baby technology in developing countries, Belgian doctors have arrived at a solution. The researchers from Genk Institute for Fer...Read more

  • Monoclonal antibodies market set to grow in Europe

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Oct, 2012

    Singapore: Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclonal antibodies based therapeutics against conventional chemical drugs...Read more

  • Teva to acquire migraine drug firm at $825 mn

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014

    Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmaceutical, is set to acquire biotechnology company focused on treatment...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls